Literature DB >> 7246686

Teratogenic hazards of oral contraceptives analyzed in a national malformation register.

E Savolainen, E Saksela, L Saxén.   

Abstract

During the period 1967-1976, prospectively collected data were available in the Finnish Register of Congenital Malformations on the contraceptive usage of 3,002 mothers of children with malformations detected at birth, as well as of time-matched and place-matched control mothers. The distributions of the various types of malformations were similar among contraceptive users (immediately prior to or during the pregnancy) and nonusers. The total incidences of various methods of contraception were also similar among mothers of malformed children and the control mothers. The risk ratio method for matched pairs allowed us to evaluate the strength of the observed negative correlation concerning oral contraceptives. Thus, we could exclude with 95% confidence any effect larger than 5% of oral contraceptives on the incidence of visible malformations.

Entities:  

Keywords:  Congenital Abnormalities; Contraception; Contraceptive Usage; Control Groups; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Fetal Death; Finland; Incidence; Literature Review; Matched Groups; Measurement; Mortality; Neonatal Diseases And Abnormalities; Northern Europe; Oral Contraceptives; Population; Population Dynamics; Prospective Studies; Research Methodology; Scandinavia; Studies

Mesh:

Substances:

Year:  1981        PMID: 7246686     DOI: 10.1016/0002-9378(81)90227-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  How safe is emergency contraception?

Authors:  Abigail Norris Turner; Charlotte Ellertson
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Barriers to contraceptive use in product labeling and practice guidelines.

Authors:  Daniel Grossman; Charlotte Ellertson; Katrina Abuabara; Kelly Blanchard; Francisco T Rivas
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.

Authors:  Mahmoud Zaqout; Emad Aslem; Mazen Abuqamar; Osama Abughazza; Joseph Panzer; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2015-05-15       Impact factor: 1.655

4.  Risk indicators of reduction limb defects.

Authors:  T Aro; O P Heinonen; L Saxén
Journal:  J Epidemiol Community Health       Date:  1983-03       Impact factor: 3.710

5.  Maternal drug histories and congenital malformations: limb reduction defects and oral clefts.

Authors:  L Hill; M Murphy; M McDowall; A H Paul
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.